Single-domain antibodies make a difference

Science. 2021 Feb 12;371(6530):681-682. doi: 10.1126/science.abg2294.

Authors

Xavier Saelens^{1

2}, Bert Schepens^{1

2}

Affiliations

¹ VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium. xavier.saelens@vib-ugent.be bert.schepens@vib-ugent.be.
² Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.

PMID: 33574203
DOI: 10.1126/science.abg2294

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Humans
SARS-CoV-2
Single-Domain Antibodies*

Substances

Single-Domain Antibodies